Áñ°Üã±â ȸ¿ø°¡ÀÔ ¿µ¹®»çÀÌÆ® my½ºÅ©·¦
BTµ¿ÇâŸÀÌÆ²
±â¼úµ¿Çâ
Á¤Ã¥µ¿Çâ
»ê¾÷µ¿Çâ
Á¦µµµ¿Çâ
ƯÇ㵿Çâ
Bio Industry
HOMEBTµ¿ÇâÁ¤Ã¥µ¿Çâ
 
´ëÇѹα¹ ¹Ì±¹ ÀϺ» ¿µ±¹ µ¶ÀÏ Ä³³ª´Ù À¯·´¿¬ÇÕ Áß±¹ Á¾ÇÕ Á¤Ã¥À̽´ ±âŸ±¹°¡
»ý¸í°øÇÐÁ¾ÇÕ¤Ó °úÇбâ¼úÀϹÝ
ÆäÀ̽ººÏ Æ®À§ÅÍ ¹ÌÅõµ¥ÀÌ  ¸¶À̽ºÅ©·¦ Àμâ
Key Biotechnology Indicators(December 2011)
ºÐ·ù Á¾ÇÕ > »ý¸í°øÇÐÁ¾ÇÕ
Ãâó OECD Á¶È¸ 2125
ÀÚ·á¹ß°£ÀÏ 2011-12-21 00:00:00.0 µî·ÏÀÏ 2012-02-03 13:49:36.0
÷ºÎÆÄÀÏ
  Key_Biotechnology_Indicators.PDF  (363755) bytes
³»¿ë¹Ù·Î°¡±â -

Key Biotechnology Indicators

(December 2011)

 

1. Biotechnology firms
KBI 1. Number of biotechnology firms
KBI 2. Percentage of small biotechnology firms (fewer than 50 employees)


2. Biotechnology R&D
KBI 3. Total biotechnology R&D expenditures in the business sector
KBI 4. Biotechnology R&D intensity
KBI 5. Percentage of biotechnology R&D performed in the services sector by dedicated biotechnology R&D firms
KBI 6. Percentage of biotechnology R&D performed by small biotechnology R&D firms (fewer than 50 employees)
 
3. Public-sector biotechnology R&D
KBI 7. Biotechnology R&D expenditures by the public sector, millions of USD PPP
KBI 8. Biotechnology R&D expenditures by the public sector as a percentage of public sector R&D
 
4. Biotechnology applications
KBI 9. Percentage of dedicated biotechnology firms by application
KBI 10. Percentage of biotechnology R&D investments by application
 
5. Biotechnology patents
KBI 11. Share of countries in biotechnology patents filed under PCT
KBI 12. Revealed technological advantage in biotechnology
 

 

.......(°è¼Ó)

 

 

¢Ñ ÀÚ¼¼ÇÑ ³»¿ëÀº ÷ºÎÆÄÀÏÀ» Âü°íÇϽñ⠹ٶø´Ï´Ù.

 

 

ÀÌÀü±Û US-EU Task Force on Biotechnology Research
´ÙÀ½±Û Biotechnology Update : Internal Co-ordination Group for Biotechnology (ICGB)
ÆäÀ̽ººÏ Æ®À§ÅÍ ¹ÌÅõµ¥ÀÌ  ¸ñ·Ï

°ü·Ã±â»ç
 
   
ÇÑ±Û ¿öµå
ÆÄ¿öÆ÷ÀÎÆ® ¾ÆÅ©·Î¹î